z-logo
open-access-imgOpen Access
Progesterone‐enhanced sperm hyperactivation through IP 3 –PKC and PKA signals
Author(s) -
Fujinoki Masakatsu
Publication year - 2013
Publication title -
reproductive medicine and biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.005
H-Index - 22
eISSN - 1447-0578
pISSN - 1445-5781
DOI - 10.1007/s12522-012-0137-6
Subject(s) - hyperactivation , protein kinase c , phospholipase c , protein kinase a , adenylate kinase , inositol , chemistry , diacylglycerol kinase , inositol phosphate , endocrinology , signal transduction , medicine , second messenger system , cyclic adenosine monophosphate , capacitation , microbiology and biotechnology , kinase , biology , receptor , biochemistry , in vitro
Propose The present study examined whether regulation of progesterone‐enhanced hyperactivation of spermatozoa is associated with the production of inositol 1,4,5‐trisphosphate (IP 3 ) and diacylglycerol (DAG) by phospholipase C (PLC) and cyclic adenosine monophosphate (cAMP) by adenylate cyclase (AC), as well as activation of protein kinase C (PKC) and protein kinase A (PKA). Methods Hamster spermatozoa were hyperactivated by incubation for 4 h in modified Tyrode's albumin lactate pyruvate (mTALP) medium. In order to examine the effects of IP 3 receptor (IP 3 R), PKC and PKA on progesterone‐enhanced hyperactivation, their inhibitors (xestospongin C, bisindolylmaleimide 1 and H‐89) were used. Results Progesterone‐enhanced hyperactivation was significantly suppressed by the inhibitors of IP 3 R, PKC and PKA. Conclusions The results suggest that progesterone‐enhanced sperm hyperactivation occurs through two signal pathways. One is an intracellular Ca 2+ signal through production of IP 3 and DAG by PLC, binding of IP 3 to IP 3 R and activation of PKC by DAG and Ca 2+ . The other is a cAMP–PKA signal through production of cAMP by AC and activation of PKA by cAMP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here